Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden.
Nguyen HT, Nguyen N, Liu LY, Dovek L, Lenchner D, Harris R, Ozer B, Ravelo A, Sommer N, Sim MS, Elashoff R, Green R, Nghiemphu PL, Cloughesy TF, Ellingson B, Lai A.
Nguyen HT, et al. Among authors: harris r.
Neurooncol Pract. 2019 Mar;6(2):103-111. doi: 10.1093/nop/npy021. Epub 2018 Sep 20.
Neurooncol Pract. 2019.
PMID: 31386050
Free PMC article.